SCHEMBL24026838

SCHEMBL24026838

CC(C)n1nccc1-c1ncccc1CI

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2C8 P10632 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ NR3C2 P08235 1/20 0.35
▸ PDE1A P54750 2/20 0.33
▸ PDE1B Q01064 2/20 0.33
▸ PDE1C Q14123 2/20 0.33
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ MAP3K12 Q12852 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15083754 0.88 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL19583170 0.87 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL15068393 0.87 CYP1A2 (0.52) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL19600203 0.87 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL21271519 0.87 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL15065399 0.85 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL19605454 0.85 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL19606106 0.85 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL25022433 0.85 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL30382604 0.85 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909941-A1 INTERMEDIATES OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE Global Blood Therapeutics, Inc. (US) 2021-11-17 — — EP disclosed
Send feedback